CytomX Therapeutics (CTMX) Return on Invested Capital (2016 - 2025)
Historic Return on Invested Capital for CytomX Therapeutics (CTMX) over the last 8 years, with Q3 2025 value amounting to 0.2%.
- CytomX Therapeutics' Return on Invested Capital rose 4300.0% to 0.2% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.2%, marking a year-over-year increase of 4300.0%. This contributed to the annual value of 1.04% for FY2024, which is 10200.0% down from last year.
- Per CytomX Therapeutics' latest filing, its Return on Invested Capital stood at 0.2% for Q3 2025, which was up 4300.0% from 0.59% recorded in Q2 2025.
- CytomX Therapeutics' 5-year Return on Invested Capital high stood at 2.91% for Q1 2025, and its period low was 2.08% during Q4 2024.
- Moreover, its 3-year median value for Return on Invested Capital was 0.02% (2023), whereas its average is 0.15%.
- As far as peak fluctuations go, CytomX Therapeutics' Return on Invested Capital crashed by -20500bps in 2024, and later skyrocketed by 31300bps in 2025.
- Quarter analysis of 3 years shows CytomX Therapeutics' Return on Invested Capital stood at 0.02% in 2023, then crashed by -9128bps to 2.08% in 2024, then surged by 110bps to 0.2% in 2025.
- Its Return on Invested Capital was 0.2% in Q3 2025, compared to 0.59% in Q2 2025 and 2.91% in Q1 2025.